Natural history of Helicobacter hepaticus infection in conventional A/J mice, with special reference to liver involvement

被引:26
作者
Avenaud, P
Le Bail, B
Mayo, K
Marais, A
Fawaz, R
Bioulac-Sage, P
Megraud, F
机构
[1] Univ Bordeaux 2, Bacteriol Lab, Bordeaux, France
[2] Univ Bordeaux 2, INSERM E0362, GREF, Bordeaux, France
关键词
D O I
10.1128/IAI.71.6.3667-3672.2003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
It has been reported that Helicobacter hepaticus infection of mice leads to chronic hepatitis and hepatocarcinoma. Our aim was to monitor a cohort of 80 conventional A/J mice in which half of the mice were infected by H. hepaticus in order to study the evolution of the infection and the pathological changes in comparison to uninfected mice. H. hepaticus was detected by culture only in some colon and cecum specimens after 17 months of age, while PCR detected H. hepaticus in the intestines of all inoculated mice after only 5 months of infection. The percentage of mice in which H. hepaticus was detected in the gallbladder, bile ducts, and liver by PCR, as well as the number of bacteria present in the liver, tended to increase with increasing age and longer infection time. Anti-H. hepaticus immunoglobulin G antibodies were positive by enzyme-linked immunosorbent assay only in inoculated mice. Pathological findings were also more frequent as the mice grew older: fibrosis was present (especially in the peripheral part of the liver), and significant portal inflammation including lymphoid nodules was present in almost all infected animals. Biliary lesions of neutrophilic acute cholangitis or lymphocytic cholangitis were noted. However, lesions were also observed in uninfected animals, although at a significantly lower level, and the only hepatocellular carcinoma occurred in an uninfected mouse. The evolution towards hepatocarcinoma is not always the endpoint and may depend on the bacterial strain and on the environmental conditions.
引用
收藏
页码:3667 / 3672
页数:6
相关论文
共 20 条
[1]  
AVENAUD P, 2000, CANCER, V13, P39
[2]   Identification of cdtB homologues and cytolethal distending toxin activity in enterohepatic Helicobacter spp. [J].
Chien, CC ;
Taylor, NS ;
Ge, ZM ;
Schauer, DB ;
Young, VB ;
Fox, JG .
JOURNAL OF MEDICAL MICROBIOLOGY, 2000, 49 (06) :525-534
[3]   Overexpression of Grb2 in inflammatory lesions and preneoplastic foci and tumors induced by N-nitrosodimethylamine in helicobacter hepaticus-infected and -noninfected A/J mice [J].
Diwan, BA ;
Ramakrishna, G ;
Anderson, LM ;
Ramljak, D .
TOXICOLOGIC PATHOLOGY, 2000, 28 (04) :548-554
[4]   LOCAL AND SYSTEMIC IMMUNE-RESPONSES IN MURINE HELICOBACTER-FELIS ACTIVE CHRONIC GASTRITIS [J].
FOX, JG ;
BLANCO, M ;
MURPHY, JC ;
TAYLOR, NS ;
LEE, A ;
KABOK, Z ;
PAPPO, J .
INFECTION AND IMMUNITY, 1993, 61 (06) :2309-2315
[5]   Persistent hepatitis and enterocolitis in germfree mice infected with Helicobacter hepaticus [J].
Fox, JG ;
Yan, L ;
Shames, B ;
Campbell, J ;
Murphy, JC ;
Li, X .
INFECTION AND IMMUNITY, 1996, 64 (09) :3673-3681
[6]   Chronic proliferative hepatitis in A/JCr mice associated with persistent Helicobacter hepaticus infection: A model of Helicobacter-induced carcinogenesis [J].
Fox, JG ;
Li, X ;
Yan, L ;
Cahill, RJ ;
Hurley, R ;
Lewis, R ;
Murphy, JC .
INFECTION AND IMMUNITY, 1996, 64 (05) :1548-1558
[7]   HELICOBACTER HEPATICUS SP-NOV, A MICROAEROPHILIC BACTERIUM ISOLATED FROM LIVERS AND INTESTINAL MUCOSAL SCRAPINGS FROM MICE [J].
FOX, JG ;
DEWHIRST, FE ;
TULLY, JG ;
PASTER, BJ ;
YAN, L ;
TAYLOR, NS ;
COLLINS, MJ ;
GORELICK, PL ;
WARD, JM .
JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (05) :1238-1245
[8]  
IARC, 1994, IARC MONOGRAPHS EVAL, VVolume 61, P1
[9]  
Josyula S, 2000, INT J ONCOL, V17, P811
[10]   Bacteria-triggered CD4+ T regulatory cells suppress Helicobacter hepaticus-induced colitis [J].
Kullberg, MC ;
Jankovic, D ;
Gorelick, PL ;
Caspar, P ;
Letterio, JJ ;
Cheever, AW ;
Sher, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (04) :505-515